Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 23305
Gene Symbol: ACSL6
ACSL6
0.010 Biomarker group BEFREE Using pooled DNA samples from cases with schizophrenia/schizoaffective disorder (Diagnostic and Statistical Manual of Mental Disorders edition IV criteria) and controls (n=200, each group), we next sequenced all exons, introns and flanking upstream/downstream sequences for ACSL6 and SIRT5. 16827919 2007
Entrez Id: 55902
Gene Symbol: ACSS2
ACSS2
0.010 Biomarker group BEFREE A formal ACS rule out troponin testing was performed in 9.2% (GI-tract disease 14.3%, non-specific chest pain 14.0%, pulmonary disease 10.0%, musculoskeletal chest pain 4.7%, and psychiatric disease 4.0%). 30707725 2019
Entrez Id: 60
Gene Symbol: ACTB
ACTB
0.010 Biomarker group BEFREE Dynamic modulation of the actin cytoskeleton is critical for synaptic plasticity, abnormalities of which are thought to contribute to mental illness and addiction. 17018287 2006
Entrez Id: 345651
Gene Symbol: ACTBL2
ACTBL2
0.020 Biomarker group BEFREE Being involved in meaningful activities and supported by others are key aspects of recovering from mental illness and are enhanced by Flexible ACT. 29373933 2018
Entrez Id: 345651
Gene Symbol: ACTBL2
ACTBL2
0.020 Biomarker group BEFREE Using a wide variety of variables that are potentially associated with treatment intensification from regular outpatient clinic to youth-ACT, we constructed a regression model illustrating a relatively strong relation between the predictor variables and the outcome (Nagelkerke R<sup>2</sup> = 0.61), with three strong predictors, i.e. severity of psychiatric disorders of the child, parental stress, and domestic violence. 30200911 2018
Entrez Id: 71
Gene Symbol: ACTG1
ACTG1
0.020 Biomarker group BEFREE Being involved in meaningful activities and supported by others are key aspects of recovering from mental illness and are enhanced by Flexible ACT. 29373933 2018
Entrez Id: 71
Gene Symbol: ACTG1
ACTG1
0.020 Biomarker group BEFREE Using a wide variety of variables that are potentially associated with treatment intensification from regular outpatient clinic to youth-ACT, we constructed a regression model illustrating a relatively strong relation between the predictor variables and the outcome (Nagelkerke R<sup>2</sup> = 0.61), with three strong predictors, i.e. severity of psychiatric disorders of the child, parental stress, and domestic violence. 30200911 2018
Entrez Id: 72
Gene Symbol: ACTG2
ACTG2
0.020 Biomarker group BEFREE Using a wide variety of variables that are potentially associated with treatment intensification from regular outpatient clinic to youth-ACT, we constructed a regression model illustrating a relatively strong relation between the predictor variables and the outcome (Nagelkerke R<sup>2</sup> = 0.61), with three strong predictors, i.e. severity of psychiatric disorders of the child, parental stress, and domestic violence. 30200911 2018
Entrez Id: 72
Gene Symbol: ACTG2
ACTG2
0.020 Biomarker group BEFREE Being involved in meaningful activities and supported by others are key aspects of recovering from mental illness and are enhanced by Flexible ACT. 29373933 2018
Entrez Id: 8728
Gene Symbol: ADAM19
ADAM19
0.100 GeneticVariation group GWASCAT A genome-wide meta-analysis identifies novel loci associated with schizophrenia and bipolar disorder. 20889312 2010
Entrez Id: 8728
Gene Symbol: ADAM19
ADAM19
0.100 GeneticVariation group GWASDB A genome-wide meta-analysis identifies novel loci associated with schizophrenia and bipolar disorder. 20889312 2010
Entrez Id: 81794
Gene Symbol: ADAMTS10
ADAMTS10
0.010 Biomarker group BEFREE We then analysed the relationships between the SNPs and psychiatric disease and various subscales of the WMS-R. 27923415 2017
Entrez Id: 104
Gene Symbol: ADARB1
ADARB1
0.020 AlteredExpression group BEFREE These findings collectively suggest that altered RNA editing efficiency of AMPA receptors due to down-regulation of ADAR2 has a possible role in the pathophysiology of mental disorders. 24443933 2014
Entrez Id: 104
Gene Symbol: ADARB1
ADARB1
0.020 GeneticVariation group BEFREE We examined the main and moderating effects of RNA editing (ADAR, ADARB1) and HTR2C genes, childhood trauma (CT), recent SLEs and psychiatric disorders as contributors to suicide attempt (SA) vulnerability. 25732952 2015
Entrez Id: 113
Gene Symbol: ADCY7
ADCY7
0.020 GeneticVariation group BEFREE Whether variations in ADCY7 and possible variations in other members of this gene family are underlying other psychiatric disorders remains to be studied. 9034014 1997
Entrez Id: 113
Gene Symbol: ADCY7
ADCY7
0.020 GeneticVariation group BEFREE We also completed studies with humans on the association of polymorphisms in the AC7 gene with major depressive illness (unipolar depression) based on Diagnostic and Statistical Manual of Mental Disorders IV criteria. 17135423 2006
Entrez Id: 116
Gene Symbol: ADCYAP1
ADCYAP1
0.050 AlteredExpression group BEFREE Taken together, our findings suggest that a balance between Ca(2+) and cAMP signals regulates PACAP levels in neurons and that a perturbation of this balance may result in psychiatric disorders, such as schizophrenia. 27383213 2016
Entrez Id: 116
Gene Symbol: ADCYAP1
ADCYAP1
0.050 Biomarker group BEFREE PACAP reduces the association of the binding between DISC1 (a potential susceptibility gene for major psychiatric disease) and DISC1-binding zinc-finger protein (which binds to DISC1 near the translocation site) to induce neurite outgrowth. 19958095 2009
Entrez Id: 116
Gene Symbol: ADCYAP1
ADCYAP1
0.050 Biomarker group BEFREE Human genetic studies suggest that the PACAP-PAC1-VPAC2 signaling can be associated with psychiatric illness via mechanisms of not only loss-of-function, but also gain-of-function. 24220567 2013
Entrez Id: 116
Gene Symbol: ADCYAP1
ADCYAP1
0.050 Biomarker group BEFREE Recently several potential susceptibility genes for major psychiatric disorders (schizophrenia and major depression) such as disrupted-in-schizophrenia 1(DISC1), dysbindin and pituitary adenylate cyclase-activating polypeptide (PACAP) have been reported. 25595671 2015
Entrez Id: 116
Gene Symbol: ADCYAP1
ADCYAP1
0.050 GeneticVariation group BEFREE Alterations in pituitary adenylate cyclase-activating polypeptide (PACAP), a multifunctional neuropeptide, and its receptors have been identified as risk factors for certain psychiatric disorders, including schizophrenia. 30886013 2019
Entrez Id: 117
Gene Symbol: ADCYAP1R1
ADCYAP1R1
0.010 Biomarker group BEFREE Human genetic studies suggest that the PACAP-PAC1-VPAC2 signaling can be associated with psychiatric illness via mechanisms of not only loss-of-function, but also gain-of-function. 24220567 2013
Entrez Id: 577
Gene Symbol: ADGRB3
ADGRB3
0.010 GeneticVariation group BEFREE Single nucleotide polymorphisms and copy number variants involving ADGRB3 have recently been associated with psychiatric disorders. 30659260 2019
Entrez Id: 125
Gene Symbol: ADH1B
ADH1B
0.020 GeneticVariation group BEFREE Those with ALDH2 *1/*1 and ADH1B *1/*1 were also likely to be at an increased risk of any mental disorder except ARD, as well as disorders without comorbid ARD. 25411394 2015
Entrez Id: 125
Gene Symbol: ADH1B
ADH1B
0.020 GeneticVariation group BEFREE We investigated the relationship of ADH1B rs1229984 and ALDH2 rs671 polymorphism combinations with mental disorder risks. 25543168 2015